scPharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 53,765 | 0.149% |
| General Public | 1,460,920 | 4.05% |
| Individual Insiders | 1,990,122 | 5.52% |
| Public Companies | 2,167,679 | 6.01% |
| Hedge Funds | 3,525,000 | 9.78% |
| VC/PE Firms | 12,132,673 | 33.7% |
| Institutions | 14,724,250 | 40.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 5,559,528 | US$22.3m | 0% | 0.31% | |||
| 3,525,000 | US$14.1m | 0.71% | 0.37% | |||
| 3,389,159 | US$13.6m | 9.09% | 5.94% | |||
| 3,183,986 | US$12.8m | 0% | 0.2% | |||
| 2,167,679 | US$8.7m | 0% | no data | |||
| 1,825,234 | US$7.3m | 0% | no data | |||
| 1,810,839 | US$7.3m | 24.6% | 0.03% | |||
| 1,801,610 | US$7.2m | -3.32% | no data | |||
| 1,369,836 | US$5.5m | 0% | no data | |||
| 1,200,647 | US$4.8m | 0% | 0.85% | |||
| 1,118,645 | US$4.5m | -20.4% | 0.2% | |||
| 1,066,704 | US$4.3m | 1.65% | 0.01% | |||
| 698,186 | US$2.8m | -7.86% | 0.96% | |||
| 576,913 | US$2.3m | 314% | no data | |||
| 575,266 | US$2.3m | 2.67% | no data | |||
| 556,186 | US$2.2m | -36.2% | 0.01% | |||
| 541,843 | US$2.2m | 0.76% | no data | |||
| 446,776 | US$1.8m | 0% | 1.33% | |||
| 281,105 | US$1.1m | 247% | 0.06% | |||
| 264,809 | US$1.1m | -1.57% | no data | |||
| 235,958 | US$946.2k | 463% | no data | |||
| 219,754 | US$881.2k | -1.46% | 0.02% | |||
| 189,084 | US$758.2k | -47% | no data | |||
| 189,000 | US$757.9k | 31.3% | 0.01% | |||
| 173,667 | US$696.4k | -11.7% | no data |